Patients Discontinuing Anti-Obesity Jabs Put On Weight Far More Rapidly Than People Using Diet and Exercise

Fresh analysis suggests that individuals who stop using new slimming jabs like semaglutide or tirzepatide can put back on lost weight far faster than those who stop conventional lifestyle plans.

Research printed in a major health publication points out that while obese individuals often shed substantial amounts of their body weight while on the medication, the mass is regained at an estimated rate of 0.8 kg per month once they quit.

"Users using these medications must be informed of the risk of rapid weight regain when the treatment concludes," cautioned expert Dr. Susan Jebb.

This pace of regain means a return to original weight in about one and a half years.

Weighing Therapies

The study, which looked at dozens of trials involving thousands of patients, compared the effects of these new drugs with other pills.

Scientists note that people who shed pounds through dieting typically have a slower weight regain—perhaps 0.1 kg a month—post-intervention.

The Reason for the Quick Regain

Doctors propose the mechanism of the drugs is key to understanding the amplified weight return.

The injections imitate a natural hormone called GLP-1, which moderates hunger.

"Artificially providing the hormone levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making binge eating a significant risk."

A Lifelong Condition?

The NHS suggest the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.

Professionals say that, due to the likelihood of relapse, the therapy is often long-term.

This perspective is reinforced by pharmaceutical companies, who note that the findings "underscore the persistent nature of obesity," similar to managing conditions like diabetes.

User Experiences

Individuals who have discontinued the medication explain a powerful return of appetite.

"I experienced a switch that goes on and you become extremely hungry," recalled an individual.

This challenge is worsened if patients have not developed lasting lifestyle or habit modifications during treatment.

Growing Use

Recent estimates show that a significant number of adults in the UK have used these injections in the last 12 months, with demand remaining high.

• Use is greater among females compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• Many access the medications through private prescriptions rather than public health services.

In conclusion, researchers emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent solution and maintained weight loss likely depends on integrated behavioural support.